Option chain shows key data for KYN Cap Gr's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for KYN Cap Gr.

KYN Cap Gr (OTC:KYNC) Stock, Option Chain

KYN Capital Group Inc is a holding company for acquisitions in entertainment, blockchain, and cryptocurrency markets. Its goal is to combine the expertise of its team members to create a cohesive force, which will carry the company forward in the marketplace. The company has released Koinfold 2.0 on IOS and Android platforms.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Penny Stocks

Small Cap

Economics

Markets

KYNC

Retail traders have joined forces in recent days in a game to pump several of Wall Street’s most shorted small-cap stocks. The aim has been to trigger a short-squeeze, and to a large extent, this does seem to have occurred. With trading activity increasingly restricted in their favorite stocks, Reddit traders appear to be turning their focus elsewhere.

Friday&#39;s Market Minute: Financial Markets Are The Ultimate Game

Movers & Shakers

Intraday Update

Movers

Trading Ideas

General

AAWW

ABACUS HEALTH PRODUCTS by Abacus Health Products Inc

ABAHF

ABMD

ACAN

ARCH BIOPARTNERS INC ORD by Arch Biopartners Inc.

ACHFF

ACNNF

ADGO

ADMP

ADMS

ADPT

ADRO

AGHC

AIHS

AKCA

ALBO

ALKS

AMFC

AMTD

ANAB

ANDE

ANGI

AOBC

APWC

ARTL

ASMB

ASRT

ASTC

AWSM

AXGN

BCDS

BEGI

BITRF

BKCC

BKPPF

BLUE

BMRN

BNKPF

BOMN

BOSSY

BSTC

BWSOF

BXEFF

CADMF

CARV

CBDS

CBDY

CBIO

CCHWF

CEIX

CHFFF

CHFS

CHAKANA COPPER CORP by Chakana Copper Corp.

CHKKF

CHOOF

CHWY

CIMDF

CLDPQ

CLRYF

CLSK

CLXT

CNCE

CNNXF

CNONF

CRBP

CRSXF

CRVS

CSLT

CSRH

CTST

CVSI

CVVUF

CWBR

CXXIF

CYTR

DAUGF

DERM

DIIBF

DRNK

DTST

DZSI

EBODF

ELOX

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

EPAY

EQTE

ETFC

EUOT

EVTN

Stocks That Hit 52-Week Lows On Tuesday

ACOR

AGGG

AMCX

AMKAF

ARLP

ATRO

ATTO

AVLIF

BACHF

BBBY

BHKLY

BIREF

BJCHF

BMWYY

BLUE PRISM GROUP PLC ORD by Blue Prism Group PLC

BPRMF

BRTX

CAKE

CARB

CATC

CDEV

CEQXF

CFWFF

CGNSF

CHMJF

COMM

CPCAY

CRTPF

CTPCY

CTTAY

CVET

CWYCY

CYCC

DDAIF

DLAKY

DMLRY

DNKEY

DSEEY

DSFGY

DSITF

EBIX

ELIO

EONGY

ESVIF

ETRN

FOCS

FORR

FUPBY

GBHL

GFSZF

GFSZY

GHSI

GIII

GNFT

GVHIB

HDSN

HNRG

HSNGY

HUSKF

IBKR

IDCBY

IDSA

IFRX

ILUS

INAP

INPX

JBFCF

JBFCY

Stocks That Hit 52-Week Lows On Thursday

KYN CAPITAL GROUP INC by KYN Capital Group, Inc.

KYN Capital Group Inc

Benchmark analyst Cody Acree upgrades Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) from Hold to Buy and maintains the price target from $160 to $160.

Upgrades

Price Target

Analyst Ratings

SLAB

Benchmark Upgrades Silicon Laboratories to Buy, Maintains Price Target to $160

Japanese automaker Toyota Motor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) on Wednesday hiked its full-year operating income outlook by 400 billion yen ($2.62 billion) to 4,700 billion yen for the financial year ending March 2025.
Upbeat Forecast: The company now expects full-year sales revenue of 47,000 billion yen and a margin of 10%, up from its previous forecast of 9.3%. 
The revised forecast reflects the company&#8217;s progress in strengthening earnings power and efforts to improve product competitiveness and value chain earnings, it said.
Weak Quarterly Results: The upbeat forecasts, however, follow a weak quarterly report. Toyota reported an operating income of 1.22 trillion yen for the three months through December, marking a drop of about 28% from the corresponding period last year, owing to a significant drop in operating income in Japan and North America.
Sales revenue in the period, however, rose marginally to 12.39 trillion yen.
Why It Matters: Toyota retained its position as the world's best-selling automaker in 2024 after <a href="https://www.benzinga.com/tech/25/01/43380849/toyota-retains-top-selling-automaker-position-while-continuing-to-trail-tesla-byd-in-ev-sales">reporting 10.8 million sales</a>, marking a dip of 4% from a year ago.
The sales numbers include those of the company's Lexus brand as well as its subsidiaries Daihatsu and Hino. Daihatsu reported sales of 536,588 units worldwide in 2024 while Hino reported sales of 125,556 units.
German automaker Volkswagen Group, in comparison, sold only about 9 million vehicles last year.
Price Action: Toyota&#8217;s NYSE-listed shares are up 2.9% in pre-market trading. The stock stock closed at $187.56 on Tuesday, down 7.6% over the past year, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro.</a> 
(1 Japanese Yen = $0.0065)
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43486319/tesla-bear-expects-ev-giants-earnings-to-fall-below-bullish-estimates-in-2025-notes-majority-of-companys-revenues-come-from-car-deliveries" target="_blank" rel="noreferrer noopener">Tesla Bear Expects EV Giant's Earnings To Fall Below Bullish Estimates In 2025, Notes Majority Of Company's Revenues Come From Car Deliveries</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

Toyota Stock Rises 3% Pre-Market After It Upgrades Full Year Forecast Despite Drop In Q3 Earnings

Telsey Advisory Group analyst Dana Telsey maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Market Perform and maintains $76 price target.

Telsey Advisory Group Maintains Market Perform on Estee Lauder Cos, Maintains $76 Price Target

DA Davidson analyst Linda Bolton Weiser maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Neutral and lowers the price target from $171 to $169.

DA Davidson Maintains Neutral on Clorox, Lowers Price Target to $169

Mizuho analyst Ben Chaiken downgrades Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) from Outperform to Neutral and raises the price target from $243 to $263.

Downgrades

Mizuho Downgrades Hilton Worldwide Holdings to Neutral, Raises Price Target to $263

Needham analyst Mike Matson reiterates TransMedics Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) from Hold to Hold.

Reiteration

TMDX

Needham Reiterates Hold on TransMedics Grto Hold

Comments

KYN Cap Gr

KYN Cap Gr (KYNC) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga